Home › Non-Small Cell Lung Cancer › Texas › Arlington
Non-Small Cell Lung Cancer clinical trials in Arlington, TX
4 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Texas Oncology - DFW, Arlington
- The Center for Cancer and Blood Disorders, Arlington
- Texas Oncology - DFW, Arlington
- and 1 more
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecruitingPhase 2/3
- Local Institution - 007-879-A, Arlington
- Local Institution - 007-879-B, Arlington
- Local Institution - 007-879-C, Bedford · 8 mi away
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Texas Oncology - DFW, Arlington
- Texas Oncology - DFW, Arlington
- Texas Oncology - DFW, Bedford · 8 mi away
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- Texas Oncology, Bedford · 8 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX143 studies
- New York City, NY123 studies
- Arlington, VA111 studies
- Nashville, TN97 studies
- Los Angeles, CA92 studies
- Boston, MA87 studies
- St. Louis, MO68 studies
- Baltimore, MD60 studies
- San Antonio, TX60 studies
- Chicago, IL59 studies
- Columbus, OH57 studies
- Seattle, WA55 studies
Other studies in Arlington
- Steatotic Liver Disease7 studies
- Non-Muscle Invasive Bladder Cancer4 studies
- Chronic Kidney Disease4 studies
- High Blood Pressure4 studies
- Rheumatoid Arthritis4 studies
- Sjögren's Disease4 studies
- Lupus3 studies
- Breast Cancer3 studies
- Ulcerative Colitis3 studies
- Bladder Cancer3 studies
- Cirrhosis3 studies
- Pneumococcal Infections3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.